Trevena to Host Conference Call to Discuss Second Quarter 2014 Results on August 12 Aug 5, 2014 7:00 am EDT
Results of Phase 1b Clinical Trial Comparing Trevena’s TRV130 to Morphine Published in the Journal Pain Jun 24, 2014 7:00 am EDT
Trevena Announces Positive Phase 1 Results for TRV734 for Acute and Chronic Pain Jun 23, 2014 7:00 am EDT
Trevena CEO to Present at the 9th Annual JMP Securities Healthcare Conference Jun 18, 2014 7:00 am EDT
Trevena Highlights Phase 2b-BLAST AHF Trial for TRV027 at the European Society of Cardiology Heart Failure 2014 Meeting May 19, 2014 7:00 am EDT